Merck's Frazier to Retire as CEO at End of July
February 04 2021 - 7:31AM
Dow Jones News
By Colin Kellaher
Merck & Co. Thursday said Kenneth Frazier, its chairman and
chief executive, will retire as CEO at the end of June.
The Kenilworth, N.J., drug maker said Robert Davis, currently
executive vice president of global services and chief financial
officer, will succeed Mr. Frazier as CEO, effective July 1.
Merck said Mr. Davis, who joined as chief financial officer in
2014, will become president on April 1, at which time the company's
four operating divisions will begin reporting to him.
Merck said Mr. Frazier, who joined the company in 1992, will
remain as executive chairman for a transition period to be
determined by the board. Mr. Frazier has been Merck's CEO since
January 2011 and chairman since December 2011.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
February 04, 2021 07:16 ET (12:16 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Merck (NYSE:MRK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Merck (NYSE:MRK)
Historical Stock Chart
From Apr 2023 to Apr 2024